| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| CMO/CDMO(元) | 33,626,783.10 | - | 35,414,398.26 |
| 喹喏酮产品(元) | 21,249,728.87 | 57,015,405.17 | 34,274,658.37 |
| 造影剂产品(元) | 1,114,375,511.73 | 1,870,009,516.53 | 1,068,159,033.63 |
| CDMO系列(元) | - | 52,104,503.56 | - |
| 其他(元) | 86,115,359.90 | 34,007,628.33 | 39,731,488.24 |
| 营业成本(元) | |||
| CMO/CDMO(元) | 33,636,489.47 | - | 30,143,792.19 |
| 喹喏酮产品(元) | 17,315,144.66 | 53,442,143.18 | 31,298,867.15 |
| 造影剂产品(元) | 913,542,833.41 | 1,447,800,326.93 | 824,145,165.36 |
| CDMO系列(元) | - | 59,163,774.46 | - |
| 其他(元) | 19,865,270.19 | 13,709,640.61 | 11,089,521.96 |
| 毛利(元) | |||
| CMO/CDMO(元) | -9,706.37 | - | 5,270,606.07 |
| 喹喏酮产品(元) | 3,934,584.21 | 3,573,261.99 | 2,975,791.22 |
| 造影剂产品(元) | 200,832,678.32 | 422,209,189.60 | 244,013,868.27 |
| CDMO系列(元) | - | -7,059,270.90 | - |
| 其他(元) | 66,250,089.71 | 20,297,987.72 | 28,641,966.28 |
| 毛利率(%) | |||
| CMO/CDMO(%) | -0.03 | - | 14.88 |
| 喹喏酮产品(%) | 18.52 | 6.27 | 8.68 |
| 造影剂产品(%) | 18.02 | 22.58 | 22.84 |
| CDMO系列(%) | - | -13.55 | - |
| 其他(%) | 76.93 | 59.69 | 72.09 |
| 收入构成(%) | |||
| CMO/CDMO(%) | 2.68 | - | 3.01 |
| 喹喏酮产品(%) | 1.69 | 2.83 | 2.91 |
| 造影剂产品(%) | 88.77 | 92.89 | 90.71 |
| CDMO系列(%) | - | 2.59 | - |
| 其他(%) | 6.86 | 1.69 | 3.37 |
| 毛利构成(%) | |||
| CMO/CDMO(%) | 0.00 | - | 1.88 |
| 喹喏酮产品(%) | 1.45 | 0.81 | 1.06 |
| 造影剂产品(%) | 74.11 | 96.17 | 86.87 |
| CDMO系列(%) | - | -1.61 | - |
| 其他(%) | 24.45 | 4.62 | 10.20 |